Get started
Author

Anju Choorakottayil Pushkaran

Understanding the Structure–Function Relationship of Lysozyme Resistance in Staphylococcus aureus by Peptidoglycan O-Acetylation Using Molecular Docking, Dynamics, and Lysis Assay
2015 · Anju C. Pushkaran, Namrata Nataraj, et al. · Journal of Chemical Information and Modeling · 88
From understanding diseases to drug design: can artificial intelligence bridge the gap?
2024 · Anju Choorakottayil Pushkaran, Alya A. Arabi · Artificial Intelligence Review · 62
PDF
Understanding the adhesion mechanism of a mucin binding domain from Lactobacillus fermentum and its role in enteropathogen exclusion
2017 · Maitrayee Chatterjee, Anju Choorakottayil Pushkaran, et al. · International Journal of Biological Macromolecules · 55
Combination of Repurposed Drug Diosmin with Amoxicillin-Clavulanic acid Causes Synergistic Inhibition of Mycobacterial Growth
2019 · Anju Choorakottayil Pushkaran, Vivek Vinod, et al. · Scientific Reports · 50
PDF
Bacterial peptidoglycan with amidated meso-diaminopimelic acid evades NOD1 recognition: an insight into NOD1 structure–recognition
2016 · Sukhithasri Vijayrajratnam, Anju Choorakottayil Pushkaran, et al. · Biochemical Journal · 37
A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main proteases
2021 · Anju Choorakottayil Pushkaran, Prajeesh Nath EN, et al. · RSC Advances · 28
PDF
Interaction mechanism of Mycobacterium tuberculosis GroEL2 protein with macrophage Lectin-like, oxidized low-density lipoprotein receptor-1: An integrated computational and experimental study
2020 · Vivek Vinod, Anju Choorakottayil Pushkaran, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 16
Accurate prediction of DNA-Intercalator binding energies: Ensemble of short or long molecular dynamics simulations?
2025 · Anju Choorakottayil Pushkaran, Alya A. Arabi · International Journal of Biological Macromolecules · 15
Understanding the molecular differential recognition of muramyl peptide ligands by LRR domains of human NOD receptors
2017 · Sukhithasri Vijayrajratnam, Anju Choorakottayil Pushkaran, et al. · Biochemical Journal · 15
Identification of a PD1/PD‐L1 inhibitor by structure‐based pharmacophore modelling, virtual screening, molecular docking and biological evaluation**
2023 · Anju Choorakottayil Pushkaran, Kumaran K, et al. · Molecular Informatics · 11
Impact of Target-Based Drug Design in Anti-bacterial Drug Discovery for the Treatment of Tuberculosis
2019 · Anju Choorakottayil Pushkaran, Raja Biswas, et al. · Challenges and advances in computational chemistry and physics · 9
A review on point mutations via proton transfer in DNA base pairs in the absence and presence of electric fields
2024 · Anju Choorakottayil Pushkaran, Alya A. Arabi · International Journal of Biological Macromolecules · 7
BMPR2 mutation and clinical response to imatinib in a case of heritable pulmonary arterial hypertension
2024 · Shine Kumar, Lalitha Biswas, et al. · Pulmonary Circulation · 3
PDF
Artificial intelligence models trained on data from molecular dynamics trajectories
2026 · Alya A. Arabi, Anju Choorakottayil Pushkaran · BMC Artificial Intelligence · 1
PDF
Ensemble molecular dynamics for predicting binding energies of DNA intercalators
2026 · Anju Choorakottayil Pushkaran, Alya A. Arabi · RSC Advances · 1
PDF
Correction to: From understanding diseases to drug design: can artificial intelligence bridge the gap?
2024 · Anju Choorakottayil Pushkaran, Alya A. Arabi · Artificial Intelligence Review
Structure-Based Bioactive Phytochemical Design from Ayurvedic Formulations Towards Spike and Mpro Druggable Targets of SARS-CoV-2
2020 · Anju Choorakottayil Pushkaran, Prajeesh Nath EN, et al. · ChemRxiv
PDF
Structure-Based Bioactive Phytochemical Design from Ayurvedic Formulations Towards Spike and Mpro Druggable Targets of SARS-CoV-2
2020 · Anju Choorakottayil Pushkaran, Prajeesh Nath EN, et al. · ChemRxiv
Works count: 18
Citation count: 398
H-index: 10
I10-index: 10
Year
Topic
Type